Drug intelligence / Profile preview

flaxseed oil + vitamin C

Development stage: Preclinical
Administration: Oral

Overview

A combination of flaxseed oil and vitamin C that has been studied primarily for its effects on Attention Deficit Hyperactivity Disorder (ADHD). Flaxseed oil provides alpha-linolenic acid (ALA), an essential omega-3 fatty acid, while vitamin C contributes antioxidant properties. This combination has been shown to improve symptoms of ADHD including hyperactivity, impulsiveness, restlessness, and self-control.

Other names: flax oil + vitamin Calpha linolenic acid + vitamin C

Beyond the preview

Go deeper on flaxseed oil + vitamin C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on flaxseed oil + vitamin C.

Explore the full profile